We provide input regarding living with CLL/SLL as patients and care partners, experience with current treatments and expectations for a new drug.
Healio spoke with Ryan. W. Jacobs, MD, about new treatments in the pipeline for CLL.
Chronic lymphocytic leukemia (CLL) is a chronic (long-term, slowly developing) leukemia. New drugs are in development for people with CLL that target cellular
lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) in late August. Lawsuits around blood cancer drugs are nothing new for
leukaemia (CLL) Researchers around the world are looking into the causes, diagnosis and treatment of CLL. They are also looking into whether new treatments are
A new drug treatment for chronic lymphocytic leukemia (CLL) and non-Hodgkin's lymphoma (NHL) is showing promise during clinical trials.
Several new drugs have been approved for CLL treatment (fludarabine, bendamustine, and the monoclonal antibodies alemtuzumab, rituximab, and ofatumumab) and
The CLL pipeline drugs market research report provides comprehensive information on the therapeutics under development for CLL
New Drug Combination for CLL Treatment. The UNITY study has introduced the promising new drug combination of umbralisib plus ublituximab as a
Comments